{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:38Z","timestamp":1791337838220,"version":"4.3.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11096-018-0681-1","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T07:27:07Z","timestamp":1531121227000},"page":"1342-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The association between polypharmacy and medication regimen complexity and antibiotic use in bronchiectasis"],"prefix":"10.1007","volume":"40","author":[{"given":"Maureen","family":"Spargo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00edn","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"681_CR1","unstructured":"Duerden M, Avery T, Payne R. Polypharmacy and medicines optimization: making it safe and sound. \n                    www.kingsfund.org.uk\/sites\/files\/kf\/field\/field_publication_file\/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf\n                    \n                   (2013). Accessed 7 Feb 2018."},{"key":"681_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00228-015-2003-z","volume":"72","author":"JA Cooper","year":"2016","unstructured":"Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Hughes CM. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria. Eur J Clin Pharmacol. 2016;72:583\u201391.","journal-title":"Eur J Clin Pharmacol"},{"key":"681_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/hex.12046","volume":"18","author":"A Sav","year":"2015","unstructured":"Sav A, King MA, Whitty JA, Kendall E, McMillan SS, Kelly F, Hunter B, Wheeler AJ. Burden of treatment for chronic illness: a concept analysis and review of the literature. Health Expect. 2015;18:312\u201324.","journal-title":"Health Expect"},{"key":"681_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/bcp.12284","volume":"77","author":"CM Hughes","year":"2014","unstructured":"Hughes CM, Cooper JA, Ryan C. Going beyond the numbers\u2014a call to redefine polypharmacy. Br J Clin Pharmacol. 2014;77:915\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"681_CR5","doi-asserted-by":"publisher","first-page":"e010505","DOI":"10.1136\/bmjopen-2015-010505","volume":"6","author":"M O\u2019Dwyer","year":"2016","unstructured":"O\u2019Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. 2016;6:e010505. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-010505\n                    \n                  .","journal-title":"BMJ Open"},{"key":"681_CR6","unstructured":"National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and multimorbidity: clinical assessment and management NICE guideline. \n                    www.nice.org.uk\/guidance\/ng56\n                    \n                   (2016). Accessed 7 Feb 2018."},{"key":"681_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1517\/14740338.2013.823944","volume":"12","author":"AM Paquin","year":"2013","unstructured":"Paquin AM, Zimmerman KM, Kostas TR, Pelletier L, Hwang A, Simone M, Skarf LM, Rudolph JL. Complexity perplexity: a systematic review to describe the measurement of medication regimen complexity. Expert Opin Drug Saf. 2013;12:829\u201340.","journal-title":"Expert Opin Drug Saf"},{"key":"681_CR8","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1345\/aph.1D479","volume":"38","author":"J George","year":"2004","unstructured":"George J, Phun YT, Bailey MJ, Kong DCM, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38:1369\u201376.","journal-title":"Ann Pharmacother"},{"key":"681_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/phar.1452","volume":"34","author":"JD Hirsch","year":"2014","unstructured":"Hirsch JD, Metz KR, Hosokawa PW, Libby AM. Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention. Pharmacotherapy. 2014;34:826\u201335.","journal-title":"Pharmacotherapy"},{"key":"681_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinthera.2013.02.019","volume":"35","author":"AM Libby","year":"2013","unstructured":"Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JD. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013;35:385\u201398.","journal-title":"Clin Ther"},{"key":"681_CR11","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cant\u00f3n R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilar\u00f3 J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629. \n                    https:\/\/doi.org\/10.1183\/13993003.00629-2017\n                    \n                  .","journal-title":"Eur Respir J"},{"key":"681_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"681_CR13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","volume":"4","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4:969\u201379.","journal-title":"Lancet Respir Med"},{"key":"681_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2466-14-107","volume":"14","author":"AR McCullough","year":"2014","unstructured":"McCullough AR, Tunney MM, Quittner AL, Elborn JS, Bradley JM, Hughes CM. Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulm Med. 2014;14:107\u201316.","journal-title":"BMC Pulm Med"},{"key":"681_CR15","volume-title":"SPSS survival manual. A step by step guide to data analysis using SPSS","author":"J Pallant","year":"2011","unstructured":"Pallant J. SPSS survival manual. A step by step guide to data analysis using SPSS. 4th ed. Crows Nest: Allen & Unwin; 2011.","edition":"4"},{"key":"681_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2318-14-72","volume":"14","author":"MC Bradley","year":"2014","unstructured":"Bradley MC, Motterlini N, Padmanabhan S, Cahir C, Williams T, Fahey T, Hughes CM. Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr. 2014;14:72\u201380.","journal-title":"BMC Geriatr"},{"key":"681_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.18549\/PharmPract.2015.04.659","volume":"13","author":"J Ferreira","year":"2015","unstructured":"Ferreira J, Ferreira JM, Galato D, Melo AC. Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract (Granada). 2015;13:659\u201367.","journal-title":"Pharm Pract (Granada)"},{"key":"681_CR18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00228-015-1883-2","volume":"71","author":"BC Wimmer","year":"2015","unstructured":"Wimmer BC, Johnell K, Fastbom J, Wiese MD, Bell JS. Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol. 2015;71:1099\u2013108.","journal-title":"Eur J Clin Pharmacol"},{"key":"681_CR19","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2147\/COPD.S136256","volume":"12","author":"NA Negewo","year":"2017","unstructured":"Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. Int J Chronic Obstr Pulm Dis. 2017;12:2929\u201342.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"681_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2125.2012.04331.x","volume":"74","author":"A Blenkinsopp","year":"2012","unstructured":"Blenkinsopp A, Bond C, Raynor DK. Medication reviews. Br J Clin Pharmacol. 2012;74:573\u201380.","journal-title":"Br J Clin Pharmacol"},{"key":"681_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.iccn.2004.11.001","volume":"21","author":"R Endacott","year":"2005","unstructured":"Endacott R, Botti M. Clinical research 3: sample selection. Intensive Crit Care Nurs. 2005;21:51\u20135.","journal-title":"Intensive Crit Care Nurs"},{"key":"681_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","volume":"47","author":"S Aliberti","year":"2016","unstructured":"Aliberti S, Lonni S, Dore S, McDonnell MJ, Goeminne PC, Dimakou K, Fardon TC, Rutherford R, Pesci A, Restrepo MI, Sotgiu G, Chalmers JD. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J. 2016;47:1113\u201322.","journal-title":"Eur Respir J"},{"key":"681_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576\u201385.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-018-0681-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0681-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0681-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T23:24:47Z","timestamp":1562628287000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-018-0681-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1007\/s11096-018-0681-1","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}